• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Biden July 4 COVID vaccine goal
Health
The U.S. won’t make the President’s July 4 vaccination target. Here’s what that means
By Sy MukherjeeJune 22, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
Juneteenth Black diversity officers health inequality
Leadership
3 Black diversity chiefs on how they’ll fight racial inequality in medicine
By Sy MukherjeeJune 18, 2021
Juneteenth Black diversity officers health inequality
Newsletters
Three Black health care diversity officers. One united goal
By Sy MukherjeeJune 17, 2021
The decade-long battle against Obamacare reaches a likely end with new Supreme Court decision
Health
The decade-long battle against Obamacare reaches a likely end with new Supreme Court decision
By Sy MukherjeeJune 17, 2021
COVID delta variant
Health
What you should know about the Delta variant and what it means for reopening
By Sy MukherjeeJune 16, 2021
COVID vaccines heart inflammation
Health
What we know about COVID vaccines, heart inflammation, and its implications for drug makers
By Sy MukherjeeJune 11, 2021
Biogen aducanumab FDA approval
Newsletters
What comes next after the Biogen Alzheimer’s drug approval
By Sy MukherjeeJune 10, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By Sy MukherjeeJune 7, 2021
New Fortune 500 CEOS 2021
Newsletters
The health care companies leading 2021’s Fortune 500 list
By Sy MukherjeeJune 3, 2021
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
Newsletters
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
By Sy MukherjeeMay 27, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
COVID vaccines military
Health
The U.S. military had a COVID vaccine skepticism problem. But now it’s seeing a massive jump in shots
By Sy MukherjeeMay 21, 2021
Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug Prices
Newsletters
Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?
By Sy MukherjeeMay 20, 2021
1
  • 2
  • 3
  • 4
  • 5
  • 6
...100
Most Popular
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.